150 related articles for article (PubMed ID: 26396099)
41. Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein.
Asada T; Isshiki R; Hayase N; Sumida M; Inokuchi R; Noiri E; Nangaku M; Yahagi N; Doi K
Sci Rep; 2016 Sep; 6():33077. PubMed ID: 27605390
[TBL] [Abstract][Full Text] [Related]
42. Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI).
Cooper DS; Claes D; Goldstein SL; Bennett MR; Ma Q; Devarajan P; Krawczeski CD
Clin J Am Soc Nephrol; 2016 Jan; 11(1):21-9. PubMed ID: 26576618
[TBL] [Abstract][Full Text] [Related]
43. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care.
Doi K; Noiri E; Sugaya T
Curr Opin Crit Care; 2010 Dec; 16(6):545-9. PubMed ID: 20736829
[TBL] [Abstract][Full Text] [Related]
44. Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
Fujita D; Takahashi M; Doi K; Abe M; Tazaki J; Kiyosue A; Myojo M; Ando J; Fujita H; Noiri E; Sugaya T; Hirata Y; Komuro I
Heart Vessels; 2015 May; 30(3):296-303. PubMed ID: 24554034
[TBL] [Abstract][Full Text] [Related]
45. A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.
Sato R; Suzuki Y; Takahashi G; Kojika M; Inoue Y; Endo S
J Infect Chemother; 2015 Mar; 21(3):165-9. PubMed ID: 25499195
[TBL] [Abstract][Full Text] [Related]
46. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease.
Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Omata M; Kimura K
Mol Cell Biochem; 2006 Mar; 284(1-2):175-82. PubMed ID: 16532260
[TBL] [Abstract][Full Text] [Related]
47. Albuminuria and other renal damage biomarkers detect acute kidney injury soon after acute ingestion of oxalic acid and potassium permanganate.
Wijerathna TM; Mohamed F; Dissanayaka D; Gawarammana I; Palangasinghe C; Shihana F; Endre Z; Shahmy S; Buckley NA
Toxicol Lett; 2018 Dec; 299():182-190. PubMed ID: 30300734
[TBL] [Abstract][Full Text] [Related]
48. The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit.
Shirakabe A; Kobayashi N; Hata N; Shinada T; Tomita K; Tsurumi M; Okazaki H; Matsushita M; Yamamoto Y; Yokoyama S; Asai K; Shimizu W
BMC Cardiovasc Disord; 2016 Sep; 16(1):174. PubMed ID: 27596162
[TBL] [Abstract][Full Text] [Related]
49. Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
Yanishi M; Kinoshita H
BMC Nephrol; 2022 Mar; 23(1):125. PubMed ID: 35361160
[TBL] [Abstract][Full Text] [Related]
50. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study.
Zappitelli M; Washburn KK; Arikan AA; Loftis L; Ma Q; Devarajan P; Parikh CR; Goldstein SL
Crit Care; 2007; 11(4):R84. PubMed ID: 17678545
[TBL] [Abstract][Full Text] [Related]
51. Urine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients.
Salim SY; Young PY; Churchill TA; Khadaroo RG
J Surg Res; 2017 Mar; 209():258-265. PubMed ID: 27555111
[TBL] [Abstract][Full Text] [Related]
52. Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation.
Yang J; Choi HM; Seo MY; Lee JY; Kim K; Jun H; Jung CW; Park KT; Kim MG; Jo SK; Cho W; Kim HK
Transplant Proc; 2014; 46(2):376-80. PubMed ID: 24655967
[TBL] [Abstract][Full Text] [Related]
53. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury.
Ren H; Zhou X; Dai D; Liu X; Wang L; Zhou Y; Luo X; Cai Q
BMC Nephrol; 2015 Aug; 16():142. PubMed ID: 26283194
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness analysis of acute kidney injury biomarkers in pediatric cardiac surgery.
Petrovic S; Bogavac-Stanojevic N; Lakic D; Peco-Antic A; Vulicevic I; Ivanisevic I; Kotur-Stevuljevic J; Jelic-Ivanovic Z
Biochem Med (Zagreb); 2015; 25(2):262-71. PubMed ID: 26110039
[TBL] [Abstract][Full Text] [Related]
55. Serum heart-type fatty acid-binding protein level can be used to detect acute kidney injury on admission and predict an adverse outcome in patients with acute heart failure.
Shirakabe A; Hata N; Kobayashi N; Okazaki H; Shinada T; Tomita K; Yamamoto M; Tsurumi M; Matsushita M; Yamamoto Y; Yokoyama S; Asai K; Shimizu W
Circ J; 2015; 79(1):119-28. PubMed ID: 25381804
[TBL] [Abstract][Full Text] [Related]
56. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N
Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of risk factors for prognosis of patients with acute paraquat intoxication].
Fengjun J; Wen Z; Taoning W; Yaying Y; Kai K; Liu M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Nov; 27(11):906-10. PubMed ID: 27132458
[TBL] [Abstract][Full Text] [Related]
58. Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.
Honore PM; Nguyen HB; Gong M; Chawla LS; Bagshaw SM; Artigas A; Shi J; Joannes-Boyau O; Vincent JL; Kellum JA;
Crit Care Med; 2016 Oct; 44(10):1851-60. PubMed ID: 27355527
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD.
Matsui K; Kamijo-Ikemori A; Imai N; Sugaya T; Yasuda T; Tatsunami S; Toyama T; Shimizu M; Furuichi K; Wada T; Shibagaki Y; Kimura K
Clin Exp Nephrol; 2016 Apr; 20(2):195-203. PubMed ID: 26189083
[TBL] [Abstract][Full Text] [Related]
60. [L-type fatty acid binding protein (L-FABP) and kidney disease].
Kamijo-Ikemori A; Sugaya T; Kimura K
Rinsho Byori; 2014 Feb; 62(2):163-70. PubMed ID: 24800492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
